(Q39408230)

English

Atrasentan, an endothelin-receptor antagonist for refractory adenocarcinomas: safety and pharmacokinetics

scientific article published on April 2002

Statements

Atrasentan, an endothelin-receptor antagonist for refractory adenocarcinomas: safety and pharmacokinetics (English)
Michael A Carducci
M Kathy Bowling
Mario A Eisenberger
Victoria Sinibaldi
Jeffrey D Isaacson
Balakrishna S Hosmane
Robert J Padley

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit